Healthy Extracts (HYEX) Cash from Operations Growth (3y) (2018 - 2025)
Healthy Extracts (HYEX) Cash from Operations Growth (3y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn | 34.90% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | -9.94% |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn | -10.80% |
| 5 | United Therapeutics | 23.19 Bn | 21.04 Bn | 648.10 Mn | 7.32% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.47 Bn | 1.16 Bn | -26.33% |
| 8 | Neurocrine Biosciences | 17.72 Bn | 16.40 Bn | 800.70 Mn | 46.81% |
| 9 | Elanco Animal Health | 12.56 Bn | 12.13 Bn | 785.00 Mn | 27.85% |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | 65.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65.16% |
| Sep 30, 2025 | -48.00% |
| Jun 30, 2025 | 32.99% |
| Mar 31, 2025 | 36.69% |
| Dec 31, 2024 | 0.81% |
| Sep 30, 2024 | 29.89% |
| Jun 30, 2024 | 91.57% |
| Mar 31, 2024 | 26.61% |
| Dec 31, 2023 | -61.65% |
| Sep 30, 2023 | 59.79% |
| Jun 30, 2023 | 66.89% |
| Mar 31, 2023 | -25.04% |
| Dec 31, 2022 | -28.44% |
| Sep 30, 2022 | 52.17% |
| Mar 31, 2022 | 63.21% |
| Dec 31, 2021 | 122.83% |
| Sep 30, 2021 | -131.52% |
| Jun 30, 2021 | 33.45% |
| Mar 31, 2021 | -50.01% |
| Dec 31, 2020 | 80.47% |